Currow DC, Plummer J, Crockett A, Abernethy A. A community population survey of prevalence and severity of dypsnoea in adults. J Pain Symptom Manage. 2009;38(4):533–44.
Bruera E, Schmitz BJP, Neumann CM, Hanson J. The frequency and correlates of dyspnoea in patients with advanced cancer. J Pain Symptom Manage. 2000;19(5):357–62.
Ripamonti C. Management of dyspnoea in advanced cancer patients. Support Care Cancer. 1999;7(4):233–43.
Mount B, Cohen P, MacDonald N, Bruera E, Dudgeon DJ. Ethical Issues in Palliative Care Research Revisited. Palliat Med. 1995;9:165–66.
Gysels M, Bausewein C, Higginson IJ. Experiences of breathlessness: A systematic review of the qualitative literature. Palliat Support Care. 2007;23(3):281–32.
Wiseman R, Rowett D, Allcroft P, Abernethy A, Currow DC. Chronic refractory dyspnoea: Evidence based management. Aust Fam Physician. 2013;42(3):137–40.
American Thoracic Society. Dyspnea. mecanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med. 1999;159:321–40.
American Thoracic Society. An official American Thoracic Society Statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.
Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P. Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18:69–78.
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.
Chhina H, Bhole VM, Goldsmith C, Hall W, Kaczorowski J, Lacaille D. Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians. J Pharm Pharm Sci. 2013;16(4):511–29.
O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, Haynes RB, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007, Issue 4. DOI: 10.1002/14651858.CD000409.pub2.
Avorn J, Soumerai SB. Improving drug therapy decisions through educational outreach: A Randomised controlled trial of academicall based detailing. New Eng J Med. 1983;308:1457–63.
Abernethy AP, Currow DC, Shelby-James TM, Rowett D, May F, Samsa GP, et al. Delivery strategies to optimize resource utilisation and performance status for patients with advanced life-limiting illness: Results from the “Palliative Care Trial” [ISRCTN 81117481]. J Pain Symptom Manage. 2013;45(3):488–505.
Nielsen LS, Svanegaard J, Wiggers P, Egeblad H. The yield of a diagnostic hospital dyspnoea clinic for the primary health care section. J Intern Med. 2001;250(5):422–28.
Dudgeon DJ, Lertzman M. Dyspnea in the advanced cancer patient. J Pain Symptom Manage. 1998;16(4):212–19.
Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, Hildebrandt PR. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice. Int J Clin Pract. 2007;61(9):1481–91.
Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;16.
Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939–44.
Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523–28.
Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, et al. Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011;42(3):388–99.
Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008;98:294–99.
Page 2nd RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4(4):297–305.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for healthcare, research and medical education: A cross-sectional study. Lancet. 2012;380:37–43.
Stevenson J, Abernethy A, Miller C, Currow DC. Managing comorbidities in patients at the end of life. Br Med J. 2004;16(329):909–12.
Bocharov MV, Khan JM. New obstacles to improve the quality of end-of-life care in ICU. Crit Care. 2012;16:304.
Linder J, Blais J, Enders S, Melberg S, Meyers F. Palliative Education: A didactic and experiential approach to teaching end-of-life care. J Cancer Educ. 1999;14(3):154–60.